Opposition councillor Noemí Amador raised concerns after families struggled to obtain ADHD prescriptions

Andorra Endavant, an opposition group in the General Council, has submitted written questions to the government regarding persistent shortages of ADHD medications, especially those containing lisdexamfetamine.

General councillor Noemí Amador brought the matter to the executive's attention following complaints from several families. These families have faced difficulties for months in accessing prescribed treatments for their children with attention deficit hyperactivity disorder (ADHD), with or without hyperactivity. The supply issues, which were already known before the summer, have yet to normalize despite the time that has passed.

In a party statement, Amador stressed the urgency of government accountability. She said families require solutions and guarantees that treatments will continue uninterrupted, along with explanations of actions taken, reasons for the ongoing problems, and steps under consideration.

The opposition group is seeking specifics from the health ministry on measures implemented to date, the factors behind Andorra's dependence on a small pool of suppliers, and efforts to diversify sources. Among the options raised is procurement from France, where lisdexamfetamine-based drugs are available. Andorra Endavant has asked whether ministry officials have contacted French authorities or distributors to explore this route, and if not, why.

The questions also cover the government's planned actions to secure reliable supplies and avoid future disruptions for families relying on these prescriptions.